WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has completed a purchase of Boulder, Colo.-based picoSpin, LLC, creators of the world’s first miniature nuclear magnetic resonance (NMR) spectrometer.
In 2010, picoSpin introduced the picoSpin-45, the world’s first miniature NMR spectrometer, offering the capabilities of larger spectrometers in a much more affordable, shoebox-sized unit. The device is ideally suited for academic, industrial and research applications where the cost, space and maintenance requirements make typical NMR spectroscopy impractical. The innovative design for the device—making it 70 times smaller than other devices of its type—earned it a 2012 R&D 100 Award from R&D Magazine (http://www.rdmag.com/award-winners/2012/08/nmr-miniaturized).
The acquisition of picoSpin augments Thermo Fisher’s portfolio of spectroscopy solutions, ranging from complementary FT-IR and UV-Vis spectroscopy to full-scale gas, liquid, isotope ratio and inductively coupled plasma mass spectrometers. The acquisition also allows Thermo Fisher Scientific to expand its array of analytical tools available to undergraduate and graduate chemistry laboratories, as well as analytical quality assurance and quality control laboratories in industry.
“Adding picoSpin’s unique product offerings to our existing capabilities in spectroscopy enables us to offer an even broader suite of chemical analysis,” said John Sos, vice president and general manager, molecular spectroscopy, Thermo Fisher Scientific. “Bringing NMR capabilities to new markets where its practicality has been limited represents significant value for our customers.”
picoSpin will be integrated primarily into the company’s chemical analysis business within the Analytical Technologies Segment. The company does not expect this transaction to have a material impact on its 2012 financial results.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit www.thermofisher.com.